Zocdoc, an online marketplace that helps patients find and book appointments with in-network providers, has partnered with healthcare ratings and patient reviews website Healthgrades, the companies ...
Trust is a major theme flowing through many of the conversations healthcare leaders are having about how to safely and effectively incorporate AI into the field, pointed out Joel Gordon, chief medical ...
The archaic practice of removing blood from the body to treat a wide range of illnesses lives on today as a standard treatment for certain blood disorders. The modern version of this approach, called ...
The deadline for extending the Affordable Care Act subsidies is approaching this month. This is happening even as consumers who depend on the ACA Marketplace are faced with the tough decision. Should ...
One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.
The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...
As employers brace for significant healthcare cost increases in 2026, many are seeking out innovative strategies to manage the impact. This comes from the Business Group on Health’s newly released ...
Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...
Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...
Ostro’s effort to boost the country’s less-than-stellar health literacy earned the startup a place in the Guinness World Records this week. The company’s virtual course now holds the record for the ...
Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...